ATE186048T1 - Vitalethin und seine anwendung in zellkultur und therapie - Google Patents

Vitalethin und seine anwendung in zellkultur und therapie

Info

Publication number
ATE186048T1
ATE186048T1 AT91915854T AT91915854T ATE186048T1 AT E186048 T1 ATE186048 T1 AT E186048T1 AT 91915854 T AT91915854 T AT 91915854T AT 91915854 T AT91915854 T AT 91915854T AT E186048 T1 ATE186048 T1 AT E186048T1
Authority
AT
Austria
Prior art keywords
vitalethin
therapy
application
cell culture
vitaletheine
Prior art date
Application number
AT91915854T
Other languages
German (de)
English (en)
Inventor
Galen Daryl Knight
Terence Joseph Scallen
Original Assignee
Univ New Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New Mexico filed Critical Univ New Mexico
Application granted granted Critical
Publication of ATE186048T1 publication Critical patent/ATE186048T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91915854T 1990-07-06 1991-07-08 Vitalethin und seine anwendung in zellkultur und therapie ATE186048T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54943890A 1990-07-06 1990-07-06
US54910590A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06

Publications (1)

Publication Number Publication Date
ATE186048T1 true ATE186048T1 (de) 1999-11-15

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915854T ATE186048T1 (de) 1990-07-06 1991-07-08 Vitalethin und seine anwendung in zellkultur und therapie

Country Status (9)

Country Link
EP (1) EP0539525B1 (en:Method)
JP (1) JP3259960B2 (en:Method)
AT (1) ATE186048T1 (en:Method)
AU (1) AU655598B2 (en:Method)
DE (1) DE69131752T2 (en:Method)
DK (1) DK0539525T3 (en:Method)
ES (1) ES2139580T3 (en:Method)
GR (1) GR3031801T3 (en:Method)
WO (1) WO1992000955A1 (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718140B2 (en) * 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
DK0538330T3 (da) * 1990-07-06 1996-02-26 Univ New Mexico Beta-Alethin-anvendelse til celledyrkning og terapi

Also Published As

Publication number Publication date
AU655598B2 (en) 1995-01-05
DE69131752T2 (de) 2000-06-29
GR3031801T3 (en) 2000-02-29
EP0539525B1 (en) 1999-10-27
JPH06500106A (ja) 1994-01-06
DK0539525T3 (da) 2000-04-10
AU8500891A (en) 1992-02-04
EP0539525A4 (en:Method) 1994-01-12
EP0539525A1 (en) 1993-05-05
HK1014367A1 (en) 1999-09-24
JP3259960B2 (ja) 2002-02-25
DE69131752D1 (de) 1999-12-02
ES2139580T3 (es) 2000-02-16
WO1992000955A1 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
ES8705845A1 (es) Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica
DE60009956D1 (de) Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
SE8703696D0 (sv) Antioxidationsmedelskomposition och forfarande for framstellning derav
BR9910251A (pt) Estimulação hematopoiética
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
DE60115618D1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
ATE76570T1 (de) Mittel zur haarbehandlung.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
ATE64270T1 (de) Fungizide verwendung eines cyanopyrrol-derivates.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE236638T1 (de) Neue verwendung von prostaglandinen
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
PT862452E (pt) Formulacao de estabilizacao para o ngf
BE899809A (fr) Compositions pour usage cosmetique avec protection de la sante et du corps.
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
EP0380692A4 (en) Plant tissue culture process
ATE186048T1 (de) Vitalethin und seine anwendung in zellkultur und therapie
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
ATE125571T1 (de) Interleukin-1-inhibitor.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee